.jpg)
.png)
Features
August 25, 2025
REPATHA® NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-C
THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food...
Read More...June 20, 2025
National Lipid Association Releases New Guidance: “LDL Cholesterol Management Simplified in Adults – Lower for Longer is Better”
The National Lipid Association (NLA) today announced the release of a major new clinical guidance document titled “LDL...
Read More...May 28, 2025
Multidisciplinary Teams in Clinical Lipidology and Cardiometabolic Care: A National Lipid Association Expert Clinical Review
This Expert Clinical Review highlights the importance of a collaborative approach to the management of dyslipidemia and...
Read More...May 19, 2025
NLA and FNLA Urge CMS and Administrator Oz to Include Low-Density Lipoprotein Cholesterol (LDL-C) Measurement in CMS Quality Measurement Programs
The National Lipid Association (NLA) and Foundation of the National Lipid Association (Foundation) urge the Centers for...
Read More...April 16, 2025
National Lipid Association Releases Expert Clinical Review on Familial Chylomicronemia Syndrome (FCS)
The National Lipid Association (NLA) has released a comprehensive clinical review titled “Familial Chylomicronemia...
Read More...